Allan Jacobson is the founder of PTC Therapeutics. PTC Therapeutics has raised $250M in total funding. Latest round: IPO.
Allan Jacobson, Ph.D., is the co-founder of PTC Therapeutics, a biopharmaceutical company that evolved from an RNA biology startup into a Nasdaq-listed entity focused on rare diseases. He was awarded the 2023 PTC Therapeutics Co-Founder recognition for his foundational role in the company's development.
Full founder directory · Investor directory · Company funding database · Fundraising library